IRWD·46333X108·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
IRWD (IRONWOOD PHARMACEUTICALS INC) is held by 121 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($46.9M), BANK OF AMERICA CORP /DE/ ($30.5M), RENAISSANCE TECHNOLOGIES LLC ($28.3M). Net institutional sentiment: Mixed.
See how IRWD's score breaks down across 4 SEC sources
Showing 1-20 of 130
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer